Increased Urinary Excretion of Aquaporin 2 in Patients with Liver Cirrhosis

Overview

Journal Gut

Specialty Gastroenterology

Date 2003 Jul 17

PMID 12865281

Citations 20

Authors

P Ivarsen

J Frokiaer

N K Aagaard

E F Hansen

F Bendtsen

S Nielsen

H Vilstrup

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Water retention is a major clinical problem in patients with liver cirrhosis. Recent research suggests that renal aquaporins may be pathophysiologically involved in this condition. The aim of the present cross sectional study of patients with liver cirrhosis was to determine if 24 hour urinary excretion of renal aquaporin 2 (AQP2) differed from that of healthy control subjects and if such excretion was related to the severity of liver disease and to the patient's water balance.

Results: Twenty four hour urinary excretion of AQP2 and free water clearance were measured in 33 stable cirrhosis patients on usual medication and in eight healthy subjects. AQP2 excretion, quantitated by immunoblotting, was eight times higher in cirrhosis patients than in controls (0.167 (0.270) U/day v 0.021 (0.017); p<0.05). Stratification according to clinical manifestations (Child- Pugh classes) revealed that it increased with the clinical severity of cirrhosis (class A 0.04 (0.04); class B 0.09 (0.16); class C 0.31 (0.35); p<0.05) but was not related to liver function, as measured by galactose elimination capacity. Excretion correlated inversely with free water clearance (rho=-0.57, p<0.01). It was higher in patients with oesophagogastric varices but not in those with ascites. Plasma vasopressin concentrations were not related to AQP2 excretion and there was no relation to dose or type of diuretic treatment.

Conclusions: Urinary AQP2 excretion was increased in patients with cirrhosis. Moreover, urinary AQP2 excretion increased with severity of cirrhosis in parallel with impairment of free water clearance. This suggests a functional association between increased AQP2 excretion and increased renal reabsorption of water in cirrhosis.

Citing Articles

Exploring Aquaporins in Human Studies: Mechanisms and Therapeutic Potential in Critical Illness.

Vrettou C, Issaris V, Kokkoris S, Poupouzas G, Keskinidou C, Lotsios N Life (Basel). 2025; 14(12.

PMID: 39768394 PMC: 11676363. DOI: 10.3390/life14121688.

Loss of Pten in Renal Tubular Cells Leads to Water Retention by Upregulating AQP2.

Sun Z, Shao X, Wu H, Zhao Y, Cao Y, Li D Kidney Dis (Basel). 2023; 9(1):58-71.

PMID: 36756085 PMC: 9900467. DOI: 10.1159/000528010.

Aquaporins in Edema.

Li N, Ying Y, Yang B Adv Exp Med Biol. 2023; 1398:281-287.

PMID: 36717501 DOI: 10.1007/978-981-19-7415-1_19.

Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure.

Chan M, Chen Y, Fan P, Lee C, Kou G, Chang C Biomedicines. 2022; 10(3).

PMID: 35327416 PMC: 8945460. DOI: 10.3390/biomedicines10030613.

Updates and Perspectives on Aquaporin-2 and Water Balance Disorders.

Noda Y, Sasaki S Int J Mol Sci. 2021; 22(23).

PMID: 34884753 PMC: 8657825. DOI: 10.3390/ijms222312950.

References

Bie P, Sandgaard N . Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol. 2000; 278(1):R1-R10. DOI: 10.1152/ajpregu.2000.278.1.R1. View

Martin P, Abraham W, Lieming X, Olson B, Oren R, Ohara M . Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol. 1999; 10(10):2165-70. DOI: 10.1681/ASN.V10102165. View

Fernandez-Llama P, Jimenez W, Bosch-Marce M, Arroyo V, Nielsen S, Knepper M . Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. Kidney Int. 2000; 58(1):216-28. DOI: 10.1046/j.1523-1755.2000.00156.x. View

Baumgarten R, van de Pol M, Deen P, Van Os C, Wetzels J . Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers. Nephrol Dial Transplant. 2000; 15(8):1155-61. DOI: 10.1093/ndt/15.8.1155. View

Pedersen R, Bentzen H, Bech J, Pedersen E . Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol. 2001; 280(5):F860-7. DOI: 10.1152/ajprenal.2001.280.5.F860. View

Nielsen S, Frokiaer J, Marples D, Kwon T, Agre P, Knepper M . Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002; 82(1):205-44. DOI: 10.1152/physrev.00024.2001. View

Guyader D, Patat A, Ellis-Grosse E, Orczyk G . Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Hepatology. 2002; 36(5):1197-205. DOI: 10.1053/jhep.2002.36375. View

Wong F, Blei A, Blendis L, Thuluvath P . A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology. 2002; 37(1):182-91. DOI: 10.1053/jhep.2003.50021. View

Tygstrup N . Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl. 1966; 18:118-25. View

10.

Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R . Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-9. DOI: 10.1002/bjs.1800600817. View

11.

Planas R, Arroyo V, Rimola A, Rodes J . Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. Gastroenterology. 1983; 84(2):247-52. View

12.

Mirouze D, Zipser R, Reynolds T . Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis. Hepatology. 1983; 3(1):50-5. DOI: 10.1002/hep.1840030108. View

13.

Madsen M, Pedersen E, Danielsen H, Jensen L, Sorensen S . Impaired renal water excretion in early hepatic cirrhosis. Lack of relationship between renal water excretion and plasma levels of arginine vasopressin, angiotensin II, and aldosterone after water loading. Scand J Gastroenterol. 1986; 21(6):749-55. DOI: 10.3109/00365528609011112. View

14.

Jespersen B, Pedersen E, Madsen M, Christensen P, Eiskjaer H, LEYSSAC P . Disturbed relationship between urinary prostaglandin E2 excretion, plasma arginine vasopressin and renal water excretion after oral water loading in early hepatic cirrhosis. Eur J Clin Invest. 1988; 18(2):202-6. DOI: 10.1111/j.1365-2362.1988.tb02414.x. View

15.

Pinzani M, Laffi G, Meacci E, LA VILLA G, Cominelli F, Gentilini P . Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites. Gastroenterology. 1988; 95(4):1081-7. DOI: 10.1016/0016-5085(88)90186-2. View

16.

Sasaki S, Fushimi K, Saito H, Saito F, Uchida S, Ishibashi K . Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest. 1994; 93(3):1250-6. PMC: 294077. DOI: 10.1172/JCI117079. View

17.

Emmeluth C, Drummer C, Gerzer R, Bie P . Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade. Acta Physiol Scand. 1994; 151(3):403-11. DOI: 10.1111/j.1748-1716.1994.tb09760.x. View

18.

Asahina Y, Izumi N, Enomoto N, Sasaki S, Fushimi K, Marumo F . Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology. 1995; 21(1):169-73. View

19.

Nielsen S, Chou C, Marples D, Christensen E, Kishore B, Knepper M . Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A. 1995; 92(4):1013-7. PMC: 42627. DOI: 10.1073/pnas.92.4.1013. View

20.

Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S . Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995; 332(23):1540-5. DOI: 10.1056/NEJM199506083322303. View